These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 22384805)

  • 1. Enzymes to die for: exploiting nucleotide metabolizing enzymes for cancer gene therapy.
    Ardiani A; Johnson AJ; Ruan H; Sanchez-Bonilla M; Serve K; Black ME
    Curr Gene Ther; 2012 Apr; 12(2):77-91. PubMed ID: 22384805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleotide-metabolizing enzymes and lymphocyte differentiation.
    Barton RW; Goldschneider I
    Mol Cell Biochem; 1979 Dec; 28(1-3):135-47. PubMed ID: 231199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PNP anticancer gene therapy.
    Zhang Y; Parker WB; Sorscher EJ; Ealick SE
    Curr Top Med Chem; 2005; 5(13):1259-74. PubMed ID: 16305530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Designer gene therapy using an Escherichia coli purine nucleoside phosphorylase/prodrug system.
    Bennett EM; Anand R; Allan PW; Hassan AE; Hong JS; Levasseur DN; McPherson DT; Parker WB; Secrist JA; Sorscher EJ; Townes TM; Waud WR; Ealick SE
    Chem Biol; 2003 Dec; 10(12):1173-81. PubMed ID: 14700625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral vectors for gene-directed enzyme prodrug therapy.
    Schepelmann S; Springer CJ
    Curr Gene Ther; 2006 Dec; 6(6):647-70. PubMed ID: 17168697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humanized ADEPT comprised of an engineered human purine nucleoside phosphorylase and a tumor targeting peptide for treatment of cancer.
    Afshar S; Asai T; Morrison SL
    Mol Cancer Ther; 2009 Jan; 8(1):185-93. PubMed ID: 19139128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy of cancer: activation of nucleoside prodrugs with E. coli purine nucleoside phosphorylase.
    Secrist JA; Parker WB; Allan PW; Bennett LL; Waud WR; Truss JW; Fowler AT; Montgomery JA; Ealick SE; Wells AH; Gillespie GY; Gadi VK; Sorscher EJ
    Nucleosides Nucleotides; 1999; 18(4-5):745-57. PubMed ID: 10432677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introduction to the background, principles, and state of the art in suicide gene therapy.
    Niculescu-Duvaz I; Springer CJ
    Mol Biotechnol; 2005 May; 30(1):71-88. PubMed ID: 15805578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammalian expression of cloned cDNA sequences encoding human purine nucleoside phosphorylase and adenosine deaminase.
    McIvor RS; Valerio D; Williams SR; Goddard JM; Simonsen CC; Duyvesteyn MG; Van Ormondt H; van der Eb AJ; Martin DW
    Ann N Y Acad Sci; 1985; 451():245-9. PubMed ID: 3935027
    [No Abstract]   [Full Text] [Related]  

  • 10. Purine pathway enzyme abnormalities in acute lymphoblastic leukemia.
    Poplack DG; Blatt J; Reaman G
    Cancer Res; 1981 Nov; 41(11 Pt 2):4821-23. PubMed ID: 6271395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine deaminase and nucleoside phosphorylase activity in patients with immunodeficiency syndromes.
    Chen SH; Ochs HD; Scott CR; Giblett ER
    Clin Immunol Immunopathol; 1979 Jun; 13(2):156-60. PubMed ID: 110506
    [No Abstract]   [Full Text] [Related]  

  • 12. Roles of alternative synthetic and catabolic purine pathways in T lymphocyte differentiation.
    Cohen A; Barankiewicz J; Gelfand EW
    Ann N Y Acad Sci; 1985; 451():26-33. PubMed ID: 3000256
    [No Abstract]   [Full Text] [Related]  

  • 13. Intranephron distribution of purine-metabolizing enzymes in rats.
    Takahashi T; Kakuno K; Yamada H; Endou H
    Ren Physiol Biochem; 1989; 12(5-6):287-94. PubMed ID: 2560234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity and effect of purine metabolizing enzymes in the digestive tract.
    Nishida Y; Hoshihara Y; Miyamoto T
    Adv Exp Med Biol; 1989; 253A():247-50. PubMed ID: 2560332
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetic delivery of enzymes for cancer therapy.
    Deonarain MP; Spooner RA; Epenetos AA
    Gene Ther; 1995 Jun; 2(4):235-44. PubMed ID: 7552983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional tumor-selective promoter targeting of E. coli purine nucleoside phosphorylase for pancreatic cancer suicide gene therapy.
    Deharvengt S; Wack S; Aprahamian M; Hajri A
    J Gene Med; 2005 May; 7(5):672-80. PubMed ID: 15580629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current progress in suicide gene therapy for cancer.
    Yazawa K; Fisher WE; Brunicardi FC
    World J Surg; 2002 Jul; 26(7):783-9. PubMed ID: 11948367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prodrug converting enzyme gene delivery by L. monocytogenes.
    Stritzker J; Pilgrim S; Szalay AA; Goebel W
    BMC Cancer; 2008 Apr; 8():94. PubMed ID: 18402662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Origins of Suicide Gene Therapy.
    Düzgüneş N
    Methods Mol Biol; 2019; 1895():1-9. PubMed ID: 30539525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purine degradative enzymes in circulating malignant cells of patients with chronic B cell neoplasia.
    Ho AD; Knauf W; Ganeshaguru K; Hunstein W; Hoffbrand AV
    Hematol Oncol; 1987; 5(1):9-17. PubMed ID: 3032762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.